Capstone Investment Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $87.7M | Buy |
95,300
+40,700
| +75% | +$41.3M | 0.15% | 63 |
|
|
2025
Q4 | $58.7M | Sell |
54,600
-65,300
| -54% | -$62.4M | 0.11% | 84 |
|
|
2025
Q3 | $91.5M | Buy |
119,900
+45,400
| +61% | +$33.8M | 0.17% | 60 |
|
|
2025
Q2 | $58.1M | Sell |
74,500
-27,300
| -27% | -$21.2M | 0.14% | 57 |
|
|
2025
Q1 | $84.1M | Sell |
101,800
-107,600
| -51% | -$89.5M | 0.22% | 48 |
|
|
2024
Q4 | $162M | Buy |
209,400
+63,200
| +43% | +$52.3M | 0.39% | 32 |
|
|
2024
Q3 | $130M | Buy |
146,200
+2,800
| +2% | +$2.52M | 0.39% | 36 |
|
|
2024
Q2 | $130M | Buy |
143,400
+37,400
| +35% | +$29.9M | 0.41% | 33 |
|
|
2024
Q1 | $82.5M | Sell |
106,000
-67,400
| -39% | -$48M | 0.3% | 47 |
|
|
2023
Q4 | $101M | Buy |
173,400
+52,300
| +43% | +$30.5M | 0.3% | 45 |
|
|
2023
Q3 | $65M | Buy |
121,100
+24,300
| +25% | +$12.5M | 0.29% | 40 |
|
|
2023
Q2 | $45.4M | Buy |
96,800
+36,000
| +59% | +$15.1M | 0.22% | 58 |
|
|
2023
Q1 | $20.9M | Sell |
60,800
-70,500
| -54% | -$23.8M | 0.11% | 124 |
|
|
2022
Q4 | $48M | Buy |
131,300
+62,100
| +90% | +$22M | 0.35% | 32 |
|
|
2022
Q3 | $22.4M | Sell |
69,200
-55,400
| -44% | -$17.6M | 0.14% | 92 |
|
|
2022
Q2 | $40.4M | Sell |
124,600
-240,500
| -66% | -$72.2M | 0.2% | 63 |
|
|
2022
Q1 | $105M | Sell |
365,100
-501,900
| -58% | -$129M | 0.29% | 38 |
|
|
2021
Q4 | $239M | Buy |
867,000
+36,400
| +4% | +$9.23M | 0.4% | 47 |
|
|
2021
Q3 | $192M | Sell |
830,600
-90,000
| -10% | -$22.2M | 0.38% | 42 |
|
|
2021
Q2 | $211M | Buy |
920,600
+248,700
| +37% | +$50M | 0.48% | 31 |
|
|
2021
Q1 | $126M | Buy |
671,900
+197,600
| +42% | +$38.7M | 0.37% | 50 |
|
|
2020
Q4 | $80.1M | Buy |
474,300
+57,100
| +14% | +$8.53M | 0.27% | 62 |
|
|
2020
Q3 | $61.8M | Buy |
417,200
+129,900
| +45% | +$20.1M | 0.32% | 52 |
|
|
2020
Q2 | $47.2M | Buy |
287,300
+28,100
| +11% | +$4.31M | 0.31% | 46 |
|
|
2020
Q1 | $36M | Sell |
259,200
-141,800
| -35% | -$19.5M | 0.58% | 19 |
|
|
2019
Q4 | $52.7M | Buy |
401,000
+97,000
| +32% | +$11.2M | 0.28% | 72 |
|
|
2019
Q3 | $34M | Buy |
304,000
+29,200
| +11% | +$3.25M | 0.23% | 91 |
|
|
2019
Q2 | $30.4M | Buy |
274,800
+108,100
| +65% | +$12.7M | 0.22% | 104 |
|
|
2019
Q1 | $21.6M | Sell |
166,700
-16,600
| -9% | -$2.02M | 0.2% | 113 |
|
|
2018
Q4 | $21.2M | Buy |
183,300
+21,500
| +13% | +$2.4M | 0.26% | 65 |
|
|
2018
Q3 | $17.4M | Buy |
161,800
+148,800
| +1,145% | +$14.9M | 0.2% | 83 |
|
|
2018
Q2 | $1.11M | Buy |
+13,000
| New | +$1.07M | 0.02% | 367 |
|
|
2017
Q1 | – | Sell |
-3,800
| Closed | -$278K | – | 1011 |
|
|
2016
Q4 | $278K | Buy |
+3,800
| New | +$283K | 0.01% | 750 |
|
|
2014
Q1 | – | Sell |
-56,100
| Closed | -$2.86M | – | 469 |
|
|
2013
Q4 | $2.86M | Buy |
+56,100
| New | +$2.81M | 0.03% | 274 |
|
Other funds holding LLY
VCM
VPM
Capstone Investment Advisors's LLY Position: Q1 2026 in Review
Capstone Investment Advisors increased its Eli Lilly (LLY) stake by 275% in Q1 2026, buying an estimated $3.8M and bringing the position to 5,107 shares worth $4.7M. The position accounts for 0.01% of the portfolio, ranked #433.
Capstone Investment Advisors first reported a position in LLY in Q3 2013 and has held it in 28 quarters since. The position peaked at $19.5M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Capstone Investment Advisors held 5,107 shares of Eli Lilly worth $4.7M as of Q1 2026.
- Capstone Investment Advisors bought 3,746 Eli Lilly shares in Q1 2026, an estimated $3.8M.
- Eli Lilly made up 0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #433 holding.
- Capstone Investment Advisors first reported a position in Eli Lilly in Q3 2013 and has held it in 28 quarters since.
- Capstone Investment Advisors's Eli Lilly position peaked at $19.5M in Q4 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.